YJP Cross Industry Forum
Adrienne Kirby, PhD, FACHE, is President and CEO of Cooper University Health Care. She is responsible for all Hospital and Ambulatory operations and oversees the physician group and the Institute structure at Cooper. Dr. Kirby leads Cooper's efforts to advance strategic healthcare partnerships and the implementation of new models of care delivery to improve quality and service and decrease cost. Dr. Kirby joined Cooper in January 2012 with more than 30 years of healthcare management experience, much of it at hospitals in the Delaware Valley. Prior to joining Cooper, Dr. Kirby served as President of Medstar Franklin Square Medical Center in Baltimore, a 380-bed community teaching hospital. Franklin Square is the third largest hospital in Maryland and has been nationally recognized for excellence in clinical quality. Prior to her accomplishments at Franklin Square, Dr. Kirby served in various leadership positions at Virtua Health, including Chief Operating Officer of Ambulatory Services and Programs of Excellence and Chief Operating Officer of Virtua Hospital Voorhees. At Virtua, she spent more than 10 years building a foundation for growth, physician partnerships and development of services and facilities. Dr. Kirby has also worked at the Hospital of the University of Pennsylvania, where she was involved in an international healthcare project in Kiev, Ukraine. Dr. Kirby has served as the chairman of numerous physician-health system joint venture boards. She serves on many boards in New Jersey including The Cooper Foundation, New Jersey Hospital Association, Hospital Alliance of New Jersey, New Jersey Council of Teaching Hospitals and the Camden County Police Foundation. In July 2016, Dr. Kirby was among the Power 50 business leaders in southern New Jersey by South Jersey Biz magazine. In June 2016, she was selected by a prestigious panel of judges to receive SJ Magazines Women of Excellence Leadership Award. Under Dr. Kirbys leadership, Cooper University Health Care was named Hospital of the Year at the 2016 Healthcare Heroes Awards sponsored by NJ Biz the states leading business journal. In May 2016, she was one of the honorees at Executive Women of New Jerseys Salute to the Policy Makers event. The International Healthcare Volunteers asked Dr. Kirby to be their 2016 Honorary Global Gala Chair. The American College of Healthcare Executives awarded the 2016 Regents Senior-Level Healthcare Executive Award to Dr. Kirby in March of 2016. In July 2015, South Jersey Biz magazine recognized September 2016 Page Dr. Kirby in its Power Players 50 Issue, highlighting the top 50 businessmen and women in the region and in March she was named as one of the 50 Most Powerful People in New Jersey Health Care. She was selected as a 2014 Woman of Distinction by the Girls Scouts of Southern and Central New Jersey for being a role model to girls and women throughout the state. In 2014, Dr. Kirby was named one of the 50 Best Women in Business by NJ BIZ magazine, one of the Top Women in Business by SNJ Business People as well as one of the Most Admired CEOs by the Philadelphia Business Journal. In 2013 and 2010, she led the Southern New Jersey American Heart Association's Go Red for Women event. Dr. Kirby has received many professional awards, including 2011 Baltimore Smart CEO BRAVA award, 2008 Community Service Award and 2005 Regent Senior Careerist award from ACHE, and the 2005 Administrative Achievement Award from the Healthcare Leadership Network of Delaware Valley. In 2003, she received the Woman of Distinction Award from the Philadelphia Business Journal. She was recognized in NJ Biz as one of 2012s Top 100 in Health Care. Dr. Kirby earned her bachelor of science in nursing degree from Rutgers University and her masters and doctoral degrees from the University of Pennsylvania. She has been a Fellow of the American College of Healthcare Executives since 2003 and a certified healthcare executive since 1998. Dr. Kirby was born at Cooper and raised in South Jersey. She lives in Cherry Hill with her husband.
Lisa David is the President and CEO of PHS. She leads the organization in successfully providing public health services to underserved families and children, offering grants and management assistance to over 200 community-based organizations, and guiding public health research and evaluation. She also provides leadership in executing long-term strategies to address the public health needs of low-income communities throughout New York City.
Lisa has over 30 years of experience in the public health and healthcare sectors. Prior to joining PHS, Lisa held positions as the Interim CEO of Medicines360, the EVP and COO of Planned Parenthood Federation of America, and the Vice Chair for Administration of the Department of Obstetrics and Gynecology at the Columbia School of Physicians and Surgeons. Lisa currently serves on the Health and Mental Health Advisory Committee for the New York City Department of Health and Mental Hygiene, and is a member of the United Hospital Fund Policy Forum. She also serves on the Board of Directors of Medicines360, and on two committees of the Human Services Council: the Value Based Payment Commission and the Priority and Strategy Council.
Sean Stiefel founded Navy Capital in 2014, where he manages a long/short portfolio focused on the Global Cannabis Sector. The Navy Capital Green Fund is the first US based Long/Short Equity Fund dedicated to Cannabis investing. Prior to founding Navy Capital, Mr. Stiefel was a research analyst and trader for Northwoods Capital Management Partners, a global long/short fund with a fundamental value and special situations investment strategy. Mr. Stiefel had previously served as an associate within an equity long/short fund at Millennium Partners, and he began his career as an equities trading analyst for Barclays Capital. He is a graduate of the University of Southern California’s Marshall School of Business. Sean has appeared on CNBC, Bloomberg, The Wall Street Journal and Financial Times.
With my Wall Street background, I am often asked why I would want to be the CEO of a specialty pharma company like ProPhase Labs.
The answer is simple: turning around companies, increasing shareholder value and protecting shareholder interests are my passion.
I financed and advised ID Biomedical, a biotech/vaccine company, when it was valued at $25 million and headed for bankruptcy. I successfully persuaded the board of directors into making difficult but necessary changes to management, including the replacement of the CEO, and helped to redirect their strategic focus. Seven years later, the company was sold to GlaxoSmithKline for more than $1.4 billion.
While advising ID Biomedical, I began a similar decade-long engagement with ProPhase Labs. After years of declining revenues, increasing losses and questionable activities, the company’s direction was in dire need of change--and the shareholders’ interests in need of protection. I initiated a risky but incredibly successful proxy contest that led to my position as CEO.
In 2010/2011, I restructured and streamlined all operations. Despite a declining category and a weak economy at that time, sales and margins of our flagship Cold-EEZE brand subsequently improved dramatically. The net result: in 2017 we sold Cold-EEZE Cold Remedy for $50 million to Mylan, a multibillion-dollar pharmaceutical company.
I approach business relationships with candor and honesty--whether I'm talking to potential investors, vendors, shareholders or employees. I motivate my team by example and get enormous satisfaction out of working hard. I believe in winning--by earning it. And most importantly, I think about what’s best for our shareholders' long-term interests in everything I do.
Specialties: Turnarounds, corporate finance & strategy, sales & marketing expertise, consumer products, biotech & pharmaceutical industries, investment strategies, securities analysis, data-driven, entrepreneurial.
Dr. Ilyayev Received his training from NY Methodist Hospital and Memorial Sloan Kettering Hospital in Manhattan. He is in the forefront of continuing education, always looking for new medical breakthroughs to help his patients.
Dr. Ilyayev started his HouseCall MD practice right after completing his residency. He realized that there were elderly homebound patients who have not seen a doctor in years. He also realized that by seeing these patients in their home, this would decrease the rate of hospitalizations thereby doing his role in decreasing our national healthcare related costs.
Dr. Erik Ilyayev’s positive attitude and self-motivation is the reason he is booked one month in advance.
This event starts on September 20th at 6:00 PM.
Join us on September 20th as we bring together our distinct industry networks for an evening of learning and connecting with new and familiar faces.
The evening kicks off with dinner, drinks, and networking, where you’ll have the opportunity to mingle with peers in various industries as well as your own. Afterward, you will take a seat at a roundtable discussion where leaders in finance, healthcare and entrepreneurship will lead industry focued roundtable discussions on topics of their expertise. The roundtable format is designed to create an open atmosphere for valuable group discussion.
Questions about this event? Please email email@example.com